Ignite Creation Date:
2025-12-25 @ 4:02 AM
Ignite Modification Date:
2026-02-24 @ 7:15 PM
Study NCT ID:
NCT06411002
Status:
COMPLETED
Last Update Posted:
2025-04-04
First Post:
2024-05-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2a Study of DaxibotulinumtoxinA-lanm for Injection in Dynamic Forehead Lines and Glabellar Lines
Sponsor:
Revance Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-08
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-02-12
Completion Date Type:
ACTUAL
First Submit Date:
2024-05-08
First Submit QC Date:
None
Study First Post Date:
2024-05-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-01
Last Update Post Date:
2025-04-04
Last Update Post Date Type:
ACTUAL